Similar studies by other investigators utilizing a renal cell carcinoma model to search for TRAIL-sensitizing agents [17] have also demonstrated that novel agents of this class can be identified by such a strategy. The gene discussed is TNFSF10; the disease is hereditary clear cell renal cell carcinoma.